Daniel Escuín
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
-
- Cancer, Hypoxia, and Metabolism 5
- Cancer-related molecular mechanisms research 4
- Cancer, Lipids, and Metabolism 3
-
- Circular RNAs in diseases 3
- Co-authors
- Paraskevi Giannakakou (11 shared papers)Jonathan W. Simons (3 shared papers)Theresa LaVallee (4 shared papers)Enrique Lerma (10 shared papers)Michelle S. Johnson (1 shared paper)Victor S. Pribluda (1 shared paper)Nicola J. Mabjeesh (1 shared paper)Glenn M. Swartz (1 shared paper)
- Journals
- Cancer Research (4 papers)Human Pathology (3 papers)International Journal of Molecular Sciences (2 papers)British Journal of Cancer (2 papers)Frontiers in Genetics (1 paper)
- Partner nations
- SpainUnited StatesBrazil
In The Last Decade
Daniel Escuín
26 papers receiving 2.2k citations
Daniel Escuín's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 915
- Oncology 575
- Molecular Biology 1.1k
- Pulmonary and Respiratory Medicine 440
- Cell Biology 236
Countries citing papers authored by Daniel Escuín
This map shows the geographic impact of Daniel Escuín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Escuín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Escuín more than expected).
Fields of papers citing papers by Daniel Escuín
This network shows the impact of papers produced by Daniel Escuín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Escuín. The network helps show where Daniel Escuín may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Escuín, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF Hit paper breakdown → | 2003 | 637 |
| 2 | 2011 | 356 | |
| 3 | 2012 | 198 | |
| 4 | 2015 | 183 | |
| 5 | 2005 | 160 | |
| 6 | 2003 | 103 | |
| 7 | 2014 | 76 | |
| 8 | 2010 | 74 | |
| 9 | 2006 | 73 | |
| 10 | 2012 | 70 | |
| 11 | 2012 | 62 | |
| 12 | 2005 | 37 | |
| 13 | 2011 | 33 | |
| 14 | 2004 | 27 | |
| 15 | 2011 | 22 | |
| 16 | 2021 | 19 | |
| 17 | 2009 | 17 | |
| 18 | 2011 | 15 | |
| 19 | 2014 | 15 | |
| 20 | 1999 | 13 |
About Daniel Escuín
Daniel Escuín is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 26 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Cancer-related molecular mechanisms research (4 papers), Microtubule and mitosis dynamics (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer, Lipids, and Metabolism (3 papers), Circular RNAs in diseases (3 papers), Cancer-related Molecular Pathways (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Cancer Research (915 citations), Oncology (575 citations), Molecular Biology (1.1k citations), Pulmonary and Respiratory Medicine (440 citations) and Cell Biology (236 citations). Daniel Escuín has collaborated with scholars based in Spain, United States and Brazil. Frequent co-authors include Paraskevi Giannakakou, Jonathan W. Simons, Theresa LaVallee, Enrique Lerma, Michelle S. Johnson, Victor S. Pribluda, Nicola J. Mabjeesh, Glenn M. Swartz, Hua Zhong and Margaret Willard. Their work appears in journals such as Cancer Research, Human Pathology, International Journal of Molecular Sciences, British Journal of Cancer and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.